Skip to Main Content

Author Details

Vicente Planelles
University of Utah
1991
158
52
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37961575Reduced Monocyte Proportions and Responsiveness in Convalescent COVID-19 Patients.bioRxiv2023
34801521Histone deacetylase inhibition reduces deleterious cytokine release induced by ingenol stimulation.Biochem Pharmacol2022
35401523Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals With Long-COVID: Identification of Diagnostic Biomarkers.Front Immunol2022
35588262HIV-1-induced type I IFNs promote viral latency in macrophages.J Leukoc Biol2022
36589263Dasatinib: effects on the macrophage phospho proteome with a focus on SAMHD1 and HIV-1 infection.Clin Res HIV AIDS2022
36742994Cytokine Deficiencies in Patients with Long-COVID.J Clin Cell Immunol2022
36238724Plasma cytokine levels reveal deficiencies in IL-8 and gamma interferon in Long-COVID.medRxiv2022
35960731Association between HLA-C alleles and COVID-19 severity in a pilot study with a Spanish Mediterranean Caucasian cohort.PLoS One2022
36298843Host Cell Redox Alterations Promote Latent HIV-1 Reactivation through Atypical Transcription Factor Cooperativity.Viruses2022
35215107HIV-1 Accessory Proteins Impart a Modest Interferon Response and Upregulate Cell Cycle-Related Genes in Macrophages.Pathogens2022
35232997ADAP1 promotes latent HIV-1 reactivation by selectively tuning KRAS-ERK-AP-1 T cell signaling-transcriptional axis.Nat Commun2022
35166645HIV-1 provirus transcription and translation in macrophages differs from pre-integrated cDNA complexes and requires E2F transcriptional programs.Virulence2022
34758609Interferon α-induced SAMHD1 regulates human cultured megakaryocyte apoptosis and proplatelet formation.Haematologica2022
33472928Interactions with Commensal and Pathogenic Bacteria Induce HIV-1 Latency in Macrophages through Altered Transcription Factor Recruitment to the LTR.J Virol2021
34969960A rapid and affordable point of care test for antibodies against SARS-CoV-2 based on hemagglutination and artificial intelligence interpretation.Sci Rep2021
34616404Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU.Front Immunol2021
34715067Pharmacologic control of homeostatic and antigen-driven proliferation to target HIV-1 persistence.Biochem Pharmacol2021
34186065Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy.Biochem Pharmacol2021
34181714Evaluation of a Surrogate Enzyme-Linked Immunosorbent Assay-Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation With Immunoglobulin G Commercial Serology Assays.Arch Pathol Lab Med2021
34154414Cleavage and Polyadenylation Specificity Factor 6 Is Required for Efficient HIV-1 Latency Reversal.mBio2021
34122423Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity.Front Immunol2021
34312614A Rapid and Affordable Point-of-care Test for Detection of SARS-Cov-2-Specific Antibodies Based on Hemagglutination and Artificial Intelligence-Based Image Interpretation.Res Sq2021
34194436Activation of the Anti-Oxidative Stress Response Reactivates Latent HIV-1 Through the Mitochondrial Antiviral Signaling Protein Isoform MiniMAVS.Front Immunol2021
33397387Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions.Virol J2021
32482680Structure-Activity Relationship Analysis of Benzotriazine Analogues as HIV-1 Latency-Reversing Agents.Antimicrob Agents Chemother2020
33375572Identification of Immunological Parameters as Predictive Biomarkers of Relapse in Patients with Chronic Myeloid Leukemia on Treatment-Free Remission.J Clin Med2020
33086748Interferon-Mediated Long Non-Coding RNA Response in Macrophages in the Context of HIV.Int J Mol Sci2020
33031540Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19.Blood Adv2020
33335944Broadly active zinc finger protein-guided transcriptional activation of HIV-1.Mol Ther Methods Clin Dev2020
33205060Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs In Vivo.Cell Rep Med2020
32828803Cytotoxic cell populations developed during treatment with tyrosine kinase inhibitors protect autologous CD4+ T cells from HIV-1 infection.Biochem Pharmacol2020
32995778Neutralization Assay with SARS-CoV-1 and SARS-CoV-2 Spike Pseudotyped Murine Leukemia Virions.bioRxiv2020
32895573Recommendations for measuring HIV reservoir size in cure-directed clinical trials.Nat Med2020
32241262The landscape of alternative splicing in HIV-1 infected CD4 T-cells.BMC Med Genomics2020
30299483Sex Influences SAMHD1 Activity and Susceptibility to Human Immunodeficiency Virus-1 in Primary Human Macrophages.J Infect Dis2019
31710657Long non-coding RNAs and latent HIV - A search for novel targets for latency reversal.PLoS One2019
31175045IFI16 Targets the Transcription Factor Sp1 to Suppress HIV-1 Transcription and Latency Reactivation.Cell Host Microbe2019
31506864Tyrosine Kinase Inhibition: a New Perspective in the Fight against HIV.Curr HIV/AIDS Rep2019
30943398Transcriptional Circuit Fragility Influences HIV Proviral Fate.Cell Rep2019
29099677Novel Latency Reversal Agents for HIV-1 Cure.Annu Rev Med2018
30104276Synthetic Ingenols Maximize Protein Kinase C-Induced HIV-1 Latency Reversal.Antimicrob Agents Chemother2018
29926732Influence of Biological Sex, Age, and HIV Status in an In Vitro Primary Cell Model of HIV Latency Using a CXCR4 Tropic Virus.AIDS Res Hum Retroviruses2018
30282829Dual TLR2 and TLR7 agonists as HIV latency-reversing agents.JCI Insight2018
29669853CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells.Sci Transl Med2018
29764952SAMHD1 Phosphorylation Coordinates the Anti-HIV-1 Response by Diverse Interferons and Tyrosine Kinase Inhibition.mBio2018
27296670CD155 on HIV-Infected Cells Is Not Modulated by HIV-1 Vpu and Nef but Synergizes with NKG2D Ligands to Trigger NK Cell Lysis of Autologous Primary HIV-Infected Cells.AIDS Res Hum Retroviruses2017
28147284Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylation.Cell Rep2017
28949981Mycobacterium tuberculosis reactivates latent HIV-1 in T cells in vitro.PLoS One2017
28524761When DNA damage is acceptable.Cell Cycle2017
26171776Modeling HIV-1 Latency in Primary T Cells Using a Replication-Competent Virus.AIDS Res Hum Retroviruses2016
  • 1 - 50 of 158

Recommended Authors

University Hospital of Wurzburg
Career Start Year 2012
Number of shared co-authors 8
Gladstone Institute of Virology, Gladstone Institutes
Career Start Year 2011
Number of shared co-authors 9
University of California san francisco
Career Start Year 2011
Number of shared co-authors 0
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2010
Number of shared co-authors 2
VA-MD Regional College of Veterinary Medicine, Virginia Tech
Career Start Year 2009
Number of shared co-authors 3
Gladstone Institutes
Career Start Year 2007
Number of shared co-authors 2
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2007
Number of shared co-authors 5
Albert Einstein College of Medicine
Career Start Year 2002
Number of shared co-authors 7
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 0
University of Edinburgh
Career Start Year 1996
Number of shared co-authors 1
University College London
Career Start Year 1995
Number of shared co-authors 6
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 9
University of California at San Francisco
Career Start Year 1994
Number of shared co-authors 1
University of Maryland School of Medicine
Career Start Year 1993
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 7
The Rockefeller University
Career Start Year 1993
Number of shared co-authors 4
University of California los angeles
Career Start Year 1992
Number of shared co-authors 4
Altius Institute for Biomedical Sciences
Career Start Year 1990
Number of shared co-authors 0
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 7
University of Massachusetts Chan Medical School
Career Start Year 1985
Number of shared co-authors 2
Fred Hutchinson Cancer Center
Career Start Year 1982
Number of shared co-authors 12
Division of Clinical Research, National Institutes of Allergy and Infectious Diseases
Career Start Year 1981
Number of shared co-authors 3
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Career Start Year 1981
Number of shared co-authors 9
Northwestern University Feinberg School of Medicine
Career Start Year 1979
Number of shared co-authors 9
Carver College of Medicine, University of Iowa
Career Start Year 1978
Number of shared co-authors 1
University of California at San Francisco
Career Start Year 1978
Number of shared co-authors 5
Boston Children's Hospital
Career Start Year 1978
Number of shared co-authors 4
Frederick National Laboratory
Career Start Year 1977
Number of shared co-authors 9
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 1
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 1972
Number of shared co-authors 2

Collaborators

George Washington University
Co-authored papers 36
University of Utah School of Medicine
Co-authored papers 6
Johns Hopkins University School of Medicine
Co-authored papers 5
Buck Institute for Research on Aging
Co-authored papers 4
Co-authored papers 4
University of Texas Southwestern Medical Center
Co-authored papers 4
University of Utah School of Medicine
Co-authored papers 4
Center for AIDS Research, University of California San Diego
Co-authored papers 3
Co-authored papers 3
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 3
University of California San Francisco
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Merck & Co. Inc.
Co-authored papers 2
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 2
Co-authored papers 2
The Scripps Research Institute
Co-authored papers 2
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 2
Wistar Institute
Co-authored papers 2
Co-authored papers 2
Gladstone Institute of Virology, USA University of California san francisco
Co-authored papers 2
University of Utah School of Medicine
Co-authored papers 2
Washington State University
Co-authored papers 2
Roche Pharma
Co-authored papers 2
California State University Long Beach
Co-authored papers 2
University of Utah School of Medicine
Co-authored papers 2
Columbia University Irving Medical Center
Co-authored papers 2
IF School of Medicine, University of Pennsylvania
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
From the Gladstone Institute of Virology and Immunology
Co-authored papers 1
University College Dublin
Co-authored papers 1